2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2018 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 3.089.570 | 252.788 | 1 | ||
2019 | 0 | 3.915.903 | 252.788 | 1 | ||
2018 | 0 | 7.766.192 | 505.577 | 2 |
Total number of partners: 52
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 52
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-04-01 | Targeted Anti-Cancer Therapies | TACT | participant | 3.089.570 | 9 |
2019-11-01 | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | Magicbullet Reloaded | participant | 3.915.903 | 15 |
2018-11-01 | pH and Ion Transport in Pancreatic Cancer | pHioniC | participant | 4.027.619 | 17 |
2018-11-01 | Integrating chemical and biological approaches to target NAD production and signaling in cancer | INTEGRATA | participant | 3.738.573 | 15 |